Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  c-Met inhibitor MSC2156119J
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
c-Met Second-Line Hepatocellular Carcinoma
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EMR 200095_005, NCI-2017-00243, 2013-002053-30, NCT02115373
Start Over